Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma
Authors:
Open Access
- 20 December 2019
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 122 (5) , 630-633
Abstract
We aimed to examine whether statin users have a lower risk of hepatocellular carcinoma (HCC) after careful consideration of prevalent statin use and cholesterol levels. During a mean prospective follow-up of 8.4 years in 400,318 Koreans, 1686 individuals were diagnosed with HCC. When prevalent users were included, HCC risk was reduced by >50% in statin users, regardless of adjustment for total cholesterol (TC). When prevalent users were excluded, new users who initiated statins within 6 months after baseline had a 40% lower risk of HCC (hazard ratio [HR] = 0.59) in a TC-unadjusted analysis. However, this relationship disappeared (HR = 1.16, 95% CI = 0.80–1.69) after adjusting for TC levels measured within 6 months before statin initiation. TC levels had strong inverse associations with HCC in each model. High cholesterol levels at statin initiation, not statin use, were associated with reduced risk of HCC. Our study suggests no protective effect of statins against HCC.Keywords
This publication has 12 references indexed in Scilit:
- Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control studyJournal of Hepatology, 2018
- Statins and Reduced Risk of Liver Cancer: Evidence for Confounding: Table 1.JNCI: Journal of the National Cancer Institute, 2016
- Meta-analysis of studies using statins as a reducer for primary liver cancer riskScientific Reports, 2016
- Statin Use and Risk of Primary Liver Cancer in the Clinical Practice Research DatalinkJNCI: Journal of the National Cancer Institute, 2015
- Opposite association between diabetes, dyslipidemia, and hepatocellular carcinoma mortality in the middle-aged and elderlyHepatology, 2014
- Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysisGastroenterology, 2013
- Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin TherapyPLOS ONE, 2012
- Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of StatinsAmerican Journal of Epidemiology, 2012
- The relationship between lipid profile and severity of liver damage in cirrhotic patients2010
- Evaluating Medication Effects Outside of Clinical Trials: New-User DesignsAmerican Journal of Epidemiology, 2003